natgillin/translations-raw huggingface dataset:
Myocardial infarction Ventricular tachy-arrhythmias Angina pectoris
Srčne bolezni palpitacija tahikardija miokardni infarkt ventrikularna tahiaritmija angina pektoris nenadna smrt
Levitra 10 mg orodispersible tablets are not bioequivalent to Levitra 10 mg film-coated tablets (see section 5.1).
Zdravilo Levitra 10 mg orodisperibilne tablete ni bioekvivalentno z zdravilom Levitra 10 mg filmsko obložene tablete (glejte poglavje 5.1).
Although specific interaction studies have not been conducted, the concomitant use of other potent CYP3A4 inhibitors (such as itraconazole) can be expected to produce vardenafil plasma levels comparable to those produced by ketoconazole.
Čeprav specifične študije medsebojnega delovanja zdravil niso bile opravljene, predvidevamo, da so pri sočasni uporabi drugih močnih zaviralcev CYP3A4 (npr. itrakonazola) plazemske ravni vardenafila primerljive s tistimi pri sočasni uporabi ketokonazola.
As this may be relevant for all patients exposed to vardenafil the patient should be advised that in the case of sudden visual defect, he should stop taking Levitra orodispersible tablets and consult immediately a physician (see section 4.3).
Ker je to pomembno za vse bolnike, ki jemljejo vardenafil, je bolnika treba opozoriti, da naj v primeru nenadne okvare vida preneha jemati zdravilo Levitra orodisperzibilne tablete in o tem nemudoma obvesti zdravnika (glejte poglavje 4.3).
7.96 mg sorbitol (E420), and 1.80 mg aspartame (E951) per orodispersible tablet.
Ena orodisperzibilna tableta vsebuje 7,96 mg sorbitola (E420) in 1,80 mg aspartama (E951).
As dizziness and abnormal vision have been reported in clinical trials with vardenafil, patients should be aware of how they react to Levitra, before driving or operating machines.
Ker so v kliničnih študijah z vardenafilom poročali o omotici in motnjah vida, morajo bolniki vedeti, kako se odzivajo na zdravilo Levitra, preden začnejo voziti ali delati s strojem.
Concomitant intake of grapefruit or grapefruit juice is expected to increase the plasma concentrations of vardenafil.
Če se zdravilo zaužije skupaj z grenivko ali grenivkinim sokom, lahko pričakujemo zvečanje plazemske koncentracije vardenafila.
As dizziness and abnormal vision have been reported in clinical trials with vardenafil, patients should be aware of how they react to Levitra orodispersible tablets, before driving or operating machines.
Ker so v kliničnih študijah z vardenafilom poročali o omotici in motnjah vida, morajo bolniki vedeti, kako se odzivajo na zdravilo Levitra orodisperzibilne tablete, preden začnejo voziti ali delati s strojem.
Patients treated with alpha-blockers should not use Levitra 10 mg orodispersible tablets as a starting dose.
Bolniki, ki se zdravijo z zaviralci adrenergičnih receptorjev alfa, ne smejo uporabiti zdravila Levitra 10 mg orodisperzibilne tablete kot začetni odmerek.
Levitra is not indicated for individuals below 18 years of age.
Uporaba zdravila Levitra ni indicirana pri osebah, mlajših od 18 let.
Levitra is not intended for use by children or adolescents under 18.
Otroci in mladostniki Zdravilo Levitra ni namenjeno otrokom ali mladostnikom, mlajšim od 18 let.
- You can take Levitra with or without food but preferably not after a heavy or high-fat meal as this may delay the effect.
Zdravilo Levitra skupaj s hrano, pijačo in alkoholom - Zdravilo Levitra lahko jemljete skupaj s hrano ali brez nje, vendar je priporočljivo, da obrok hrane ni težak in ne vsebuje veliko maščob, ker lahko zakasni učinek zdravila.
Levitra allows an erection to last long enough for you to satisfactorily complete sexual activity.
Zdravilo Levitra pomaga ohraniti erekcijo toliko časa, da lahko uspešno zaključite spolni odnos.
At a dose of 20 mg Levitra film-coated tablets, elderly (≥ 65 years old) patients had higher frequencies of headaches (16.2% versus 11.8%) and dizziness (3.7% versus 0.7%) than younger patients (<65 years old).
Starejši bolniki (≥ 65 let) so pri uporabi zdravila Levitra 20 mg filmsko obložene tablete imeli bolj pogosto glavobole (16,2 % oz. 11,8 %) in omotice (3,7 % oz. 0,7 %) kot mlajši bolniki (< 65 let).
After oral dosing of vardenafil AUC and Cmax increase almost dose proportionally over the recommended dose range (5 - 20 mg).
Vrednosti AUC in Cmax se po peroralni uporabi priporočenih odmerkov vardenafila (5 do 20 mg) večata skoraj sorazmerno z odmerkom.
When nitric oxide is released in response to sexual stimulation, inhibition of PDE5 by vardenafil results in increased corpus cavernosum levels of cGMP.
Ko se dušikov oksid zaradi spolnega vzburjenja sprosti, vardenafil zavira PDE5 in povzroči zvišanje ravni cGMP v kavernoznem tkivu.
Concomitant use of riociguat with PDE5 inhibitors, including vardenafil, is contraindicated (see section 4.3).
Sočasna uporaba riociguata z zaviralci PDE5, vključno z vardenafilom, je kontraindicirana (glejte poglavje 4.3).
As this may be relevant for all patients exposed to vardenafil the patient should be advised that in the case of sudden visual defect, he should stop taking Levitra and consult immediately a physician (see section 4.3).
Ker je to pomembno za vse bolnike, ki jemljejo vardenafil, je bolnika treba opozoriti, da naj v primeru nenadne okvare vida preneha jemati zdravilo Levitra in o tem nemudoma obvesti zdravnika (glejte poglavje 4.3).
In a penile plesthysmography (RigiScan) study, vardenafil 20 mg produced erections considered sufficient for penetration (60% rigidity by RigiScan) in some men as early as 15 minutes after dosing.
V študiji so s pletizmografijo penisa (RigiScan) ugotovili, da je 20-miligramski odmerek vardenafila pri nekaterih moških že v 15 minutah po odmerjanju povzročil erekcijo, ki je zadostovala za penetracijo (60-odstotna otrdelost glede na RigiScan).
Whatever the cause is, due to muscle and blood vessel changes not enough blood stays in the penis to make it hard and keep it hard.
Bolezenske spremembe gladkih mišic in okvare v steni krvnih žil lahko povzročijo, da v penisu ni dovolj krvi, da bi otrdel in tudi ostal trd.
Vardenafil AUC and Cmax in elderly patients (65 years or over) taking vardenafil orodispersible tablets were increased by 31 to 39% and 16 to 21%, respectively, in comparison to patients aged 45 years and below.
Pri starejših bolnikih (65 let in več), ki so jemali orodisperzibilne tablete, ki so vsebovale vardenafil, sta se AUC in Cmax vardenafila povečala od 31 do 39 % oziroma 16 do 21%, v primerjavi z bolniki starimi 45 let in manj.
In humans vardenafil had no effect on bleeding time alone or in combination with acetylsalicylic acid (see section 4.5).
Vardenafil pri človeku niti sam niti v kombinaciji z acetilsalicilno kislino ne vpliva na čas krvavitve (glejte poglavje 4.5).
Levitra orodispersible tablets must be taken without liquid and immediately upon release from the blister.
Zdravilo Levitra orodisperzibilne tablete je treba vzeti brez tekočine, takoj, ko se odpre pretisni omot.
In two interaction studies with healthy normotensive volunteers after forced titration of the alpha-blockers tamsulosin or terazosin to high doses, hypotension (in some cases symptomatic) was reported in a significant number of subjects after co-administration of vardenafil.
V dveh študijah o medsebojnem delovanju zdravil, v katerih so sodelovali zdravi prostovoljci, ki so imeli normalen krvni tlak, se je po pospešeni titraciji zaviralcev adrenergičnih receptorjev alfa tamsulozina oziroma terazosina do velikih odmerkov pri pomembnem številu preiskovancev po sočasnem zaužitju vardenafila pojavila hipotenzija (ki je bila v nekaterih primerih simptomatska).
Levitra 10 mg orodispersible tablets are not for use in patients with moderate (Child-Pugh B) and severe hepatic impairment (Child-Pugh C; see section 4.3).
Zdravilo Levitra 10 mg orodisperzibilne tablete ni indicirano pri bolnikih z zmerno (Child-Pugh B) in hudo jetrno okvaro (Child-Pugh C; glejte poglavje 4.3).
In a specific study, where vardenafil (20 mg) was co-administered with slow release nifedipine (30 mg or 60 mg) in hypertensive patients, there was an additional reduction on supine systolic blood pressure of 6 mmHg and supine diastolic blood pressure of 5 mmHg accompanied with an increase in heart rate of 4 bpm.
V posebni študiji, v kateri so bolniki s hipertenzijo jemali vardenafil (20 mg) sočasno z nifedipinom v obliki s počasnim sproščanjem (30 mg ali 60 mg), se jim je sistolični krvni tlak leže dodatno znižal za 6 mmHg, diastolični za 5 mmHg, srčna frekvenca pa se je zvečala za 4 utripe na minuto.
The response rates for the ability to obtain and maintain an erection were 76% and 59% on vardenafil compared to 41% and 22% on placebo for patients who completed three months treatment which were clinically and statistically significant (p<0.001).
Po tromesečnem zdravljenju je bila odzivnost bolnikov glede zmožnosti doseganja in ohranjanja erekcije 76- oz. 59-odstotna pri bolnikih, ki so jemali vardenafil, ter 41- oz. 22-odstotna pri tistih, ki so dobivali placebo, kar je bilo klinično in statistično pomembno (p < 0,001).
How to take Levitra
Kako jemati zdravilo Levitra
Men who take too much Levitra may experience more side effects or may get severe back pain.
Če ste vzeli večji odmerek zdravila Levitra, kot bi smeli Pri moških, ki so vzeli večji odmerek, se lahko pojavi več neželenih učinkov ali pa hude bolečine v križu.
Concomitant use of vardenafil with HIV protease inhibitors such as ritonavir and indinavir is contraindicated, as they are very potent inhibitors of CYP3A4 (see section 4.5).
Sočasna uporaba vardenafila in zaviralcev HIV-proteaze, kot sta ritonavir in indinavir, je kontraindicirana, ker sta zelo močna zaviralca CYP3A4 (glejte poglavje 4.5).
The pharmacokinetics of vardenafil in patients with severely impaired hepatic function (Child-Pugh C) has not been studied (see section 4.3).
Farmakokinetika vardenafila pri bolnikih s hudo jetrno okvaro (Child-Pugh C) ni raziskana (glejte poglavje 4.3).
However, there is no information on the possible potentiation of the hypotensive effects of nitrates by vardenafil in patients, and concomitant use of Levitra orodispersible tablets and nitrates is therefore contraindicated (see section 4.3).
Ni pa podatkov o tem, ali vardenafil zveča hipotenzijski učinek nitratov, zato je sočasna uporaba zdravila Levitra orodisperzibilne tablete in nitratov kontraindicirana (glejte poglavje 4.3).
The adverse reactions reported with Levitra film-coated tablets or 10 mg orodispersible tablets in clinical trials were generally transient and mild to moderate in nature.
Neželeni učinki o katerih so poročali v kliničnih preskušanjih pri uporabi zdravila Levitra filmsko obložene tablete ali Levitra 10 mg orodisperzibilne tablete so bili v glavnem prehodni in blagi do zmerni.
Please tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription.
Druga zdravila in zdravilo Levitra Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
Therefore, concomitant treatment should be initiated only if the patient is stable on his alpha-blocker therapy.
Sočasno zdravljenje z vardenafilom se lahko začne samo, če je bolnikovo zdravstveno stanje pri zdravljenju z zaviralcem adrenergičnih receptorjev alfa stabilno.
Levitra 10 mg orodispersible tablets are round and white.
Zdravilo Levitra 10 mg orodisperzibilne tablete so okrogle, bele tablete.
No dose adjustment is required in patients with mild to moderate renal impairment.
Bolnikom z blago do zmerno ledvično okvaro odmerka ni treba prilagajati.
Hypotension was not observed when vardenafil 5 mg and terazosin administration was separated by 6 hours.
Ta se ni pojavila, če je od zaužitja 5 mg vardenafila do zaužitja terazosina minilo šest ur.
The vardenafil results showed an increase in QTc (Fridericia) of 8 msec (90% CI: 6-9) and 10 msec (90% CI: 8-11) at 10 and 80 mg doses compared to placebo and an increase in QTci of 4 msec (90% CI: 3-6) and 6 msec (90% CI: 4-7) at 10 and 80 mg doses compared to placebo, at one hour post-dose.
Raziskovalci so ugotovili, da se eno uro po zaužitju 10- ali 80miligramskega odmerka vardenafila QTc (Fridericia) zveča za 8 msec (90-odstotni interval zaupanja: 6-9) in 10 msec (90-odstotni interval zaupanja: 8-11) v primerjavi s placebom, QTci za 4 msec (90odstotni interval zaupanja: 3-6) in 6 msec (90-odstotni interval zaupanja: 4-7).
This medicine contains 1.80 mg aspartame in each 10 mg orodispersible tablet.
To zdravilo vsebuje 1,80 mg aspartama v vsaki 10-mg orodisperzibilni tableti.
Patients with mild hepatic impairment should start treatment with Levitra 5 mg film-coated tablets.
Bolniki z blago jetrno okvaro morajo zdravljenje začeti z zdravilom Levitra 5 mg filmsko obložene tablete.
No clinical trials in CNS diseases (except spinal cord injury), patients with severe renal or hepatic impairment, pelvic surgery (except nerve-sparing prostatectomy) or trauma or radiotherapy and hypoactive sexual desire or penile anatomic deformities have been performed.
V preskušanja niso bili vključeni bolniki z boleznimi osrednjega živčevja (razen bolniki s poškodbo hrbtenjače), hudimi motnjami pri delovanju ledvic ali jeter, bolniki, ki so imeli poškodbo, kirurški poseg v medenici (razen odstranitve prostate z ohranitvijo živcev), bolniki na radioterapiji in bolniki z zmanjšanim spolnim poželenjem ali anatomskimi deformacijami penisa.
It reduces the action of the natural chemical in your body which makes erections go away.
Zdravilo Levitra zavira delovanje naravne kemične spojine v vašem telesu, ki povzroči uplahnitev penisa.
Cases of sudden death, fast or altered heart beat, heart attack, chest pain, and trouble in cerebral circulation (including temporarily decreased blood flow to parts of the brain and bleeding in the brain) have been reported in men taking vardenafil.
Pri moških, ki so jemali vardenafil, so poročali o primerih nenadne smrti, hitrem ali spremenjenem srčnem utripu, srčnem napadu, bolečinah v prsnem košu in motnjah v možganskem krvnem obtoku (vključno z začasno zmanjšanim pretokom krvi v določenih delih možganov in krvavitvi v možganih).
Nicorandil is a hybrid of potassium channel opener and nitrate.
Nikorandil je mešanec aktivatorja kalijevih kanalčkov in nitrata.
The ability to maintain the erection (SEP 3) in this broad ED population was given as 53% (5 mg), 63% (10 mg) and 65% (20 mg) compared to 29% on placebo.
Zmožnost ohranjanja erekcije (SEP 3) v tej širši populaciji moških z ED je bila 53-odstotna (5 mg), 63- (10 mg) in 65-odstotna (20 mg) pri bolnikih, ki so jemali vardenafil, in 29-odstotna pri tistih, ki so dobivali placebo.
Therefore the orodispersible formulation should not be used as an equivalent to vardenafil 10 mg film-coated tablets.
Orodisperzibilnih tablet se zato ne sme uporabljati kot ekvivalent filmsko obloženim tabletam po 10 mg vardenafila.
Mean vardenafil AUC was increased by 21 to 29% (middle aged and elderly ED patients) or 44% (young healthy subjects) with 10 mg orodispersible tablets compared to film-coated tablets as a result of local oral absorption of a small amount of drug in the oral cavity.
Povprečna vrednost AUC za vardenafil je povečana za 21 do 29 % (pri bolnikih v srednjih letih ali starejših bolnikih z erektilno disfunkcijo) ali 44 % (pri mlajših bolnikih), pri bolnikih, ki jemljejo 10-miligramske orodisperzibilne tablete v primerjavi z jemanjem filmsko obloženih tablet.
Vardenafil pharmacokinetics has not been studied in patients requiring dialysis (see section 4.3).
Farmakokinetika vardenafila ni raziskana pri bolnikih na dializi (glejte poglavje 4.3).
- Medicine for the treatment of arrhythmias, such as quinidine, procainamide, amiodarone or sotalol.
- zdravila za zdravljenje aritmij, npr. kinidin, prokainamid, amiodaron ali sotalol, - ritonavir ali indinavir - zdravili za HIV.
The co-administration of PDE5 inhibitors, including vardenafil, with guanylate cyclase stimulators, such as riociguat, is contraindicated as it may potentially lead to symptomatic hypotension (see section
Sočasna uporaba zaviralcev PDE5, vključno z vardenafilom, s stimulatorji gvanilat-ciklaze, kot je riociguat, je kontraindicirana, saj lahko privede do simptomatske hipotenzije (glejte poglavje 4.5).
Vardenafil in film-coated tablets is metabolised predominantly by hepatic metabolism via cytochrome P450 (CYP) isoform 3A4 with some contribution from CYP3A5 and CYP2C isoforms.
Vardenafil iz filmsko obloženih tablet se presnavlja predvsem v jetrih s pomočjo citokroma P450 (CYP), izooblike 3A4, pri čemer nekoliko prispevata tudi izoobliki CYP3A5 in CYP2C.
Grapefruit juice being a weak inhibitor of CYP3A4 gut wall metabolism, may give rise to modest increases in plasma levels of vardenafil (see section 4.4).
Ker je grenivkin sok šibak zaviralec presnove CYP3A4 v steni prebavil, lahko povzroči rahlo zvišanje plazemske ravni vardenafila (glejte poglavje 4.4).
Film coat: macrogol 400, hypromellose, titanium dioxide (E171), ferric oxide yellow (E172), ferric oxide red (E172).
filmska obloga: makrogol 400, hipromeloza, titanov dioksid (E171), rumeni železov oksid (E172), rdeči železov oksid (E172).
Bayer SA-NV Tél/Tel: +32-(0)2-535 63 11
Luxembourg/Luxemburg Bayer SA-NV Tél/Tel: +32-(0)2-535 63 11
The number of patients who returned to a normal IIEF domain score (>26) were 53% on vardenafil compared to 9% on placebo.
53-odstotkov bolnikov, ki so jemali vardenafil je ponovno imelo normalno erektilno funkcijo (> 26) v primerjavi z 9-odstotki bolnikov, ki so jemali placebo.
• When vardenafil (film-coated tablets) was given at doses of 5, 10 or 20 mg on a background of stable therapy with tamsulosin, there was no symptomatic reduction in blood pressure, although 3/21 tamsulosin treated subjects exhibited transient standing systolic blood pressures of less than 85 mmHg.
• Pri bolnikih, ki so se zdravili s tamsulozinom in katerih zdravstveno stanje je bilo stabilno, jemanje filmsko obloženih tablet po 5-, 10- ali 20 mg vardenafila ni povzročilo simptomatskega znižanja krvnega tlaka, čeprav je stoje izmerjen sistolični krvni tlak pri treh bolnikih (od 21, ki so se zdravili s tamsulozinom), prehodno znašal manj kot 85 mmHg.
In single dose volunteer studies, doses up to and including 80 mg vardenafil (film-coated tablets) per day were tolerated without exhibiting serious adverse reactions.
V študiji, v kateri so prostovoljci na dan zaužili en odmerek, manjši ali enak 80 mg vardenafila (filmsko obložene tablete), so ugotovili, da so zdravilo dobro prenašali in niso imeli resnih neželenih učinkov.
Concomitant use of vardenafil with the potent CYP3A4 inhibitors ketoconazole and itraconazole (oral form) is contraindicated in men older than 75 years.
Sočasna uporaba vardenafila in močnih zaviralcev CYP3A4, kot sta ketokonazol in itrakonazol (za peroralno uporabo), je pri moških, starih več kot 75 let, kontraindicirana.
Serious cardiovascular events including sudden death, tachycardia, myocardial infarction, ventricular tachy-arrythmia, angina pectoris, and cerebrovascular disorders (including transient ischaemic attack and cerebral haemorrhage), have been reported in temporal association with vardenafil.
V časovni povezavi z uporabo vardenafila so poročali o resnih kardiovaskularnih dogodkih, med drugim o nenadni smrti, tahikardiji, miokardnem infarktu, ventrikularni tahiaritmiji, angini pektoris in cerebrovaskularnih motnjah (vključno z tranzitornim ishemičnim napadom in možgansko krvavitvijo).
The safety of vardenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated until further information is available: - severe hepatic impairment (Child-Pugh C), - end stage renal disease requiring dialysis, - hypotension (blood pressure <90/50 mmHg), - recent history of stroke or myocardial infarction (within the last 6 months), - unstable angina and known hereditary retinal degenerative disorders such as retinitis pigmentosa.
Varnost vardenafila ni raziskana v podskupinah bolnikov, - ki imajo hude motnje pri delovanju jeter (Child-Pugh C), - ki imajo končno ledvično odpoved, ki zahteva dializno zdravljenje, - ki imajo hipotenzijo (krvni tlak < 90/50 mmHg), - ki so doživeli možgansko kap ali miokardni infarkt (v zadnjih šestih mesecih), - ki imajo nestabilno angino pektoris in znano dedno degenerativno bolezen mrežnice (retinitis pigmentosa).
In pooled data from the two vardenafil 10 mg orodispersible tablets trials, IIEF-EF domain scores were significantly higher with vardenafil 10 mg orodispersible tablet versus placebo.
V zbranih podatkih iz dveh kliničnih preskušanj z orodisperzibilnimi tabletami po 10 mg vardenafila, je bila vrednost IIEF-EF pomembno večja pri orodisperzibilnih tabletah po 10 mg vardenafila v primerjavi s placebom.
Tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, colloidal anhydrous silica.
jedro tablete: krospovidon, magnezijev stearat, mikrokristalna celuloza, brezvoden koloidni silicijev dioksid;
Vardenafil is metabolised predominantly by hepatic enzymes via cytochrome P450 (CYP) isoform 3A4, with some contribution from CYP3A5 and CYP2C isoforms.
Vardenafil se v glavnem presnavlja s pomočjo jetrnih encimov prek citokroma P450 (CYP), izooblike 3A4; sodelujeta tudi izoobliki CYP3A5 in CYP2C.
In patients with moderate impairment (Child-Pugh B), the mean AUC and Cmax increased by 160% and 133% respectively, compared to healthy control subjects (see section 4.2).
Pri bolnikih z zmerno jetrno okvaro (Child-Pugh B) sta se povprečni vrednosti AUC in Cmax v primerjavi z zdravimi preiskovanci iz kontrolne skupine zvečali za 160 % oz. 133 % (glejte poglavje 4.2).
Levitra 5 mg film-coated tablets Levitra10 mg film-coated tablets Levitra 20 mg film-coated tablets
Levitra 5 mg filmsko obložene tablete Levitra 10 mg filmsko obložene tablete Levitra 20 mg filmsko obložene tablete
No significant interactions were shown when warfarin (25 mg), which is metabolised by CYP2C9, or digoxin (0.375 mg) was co-administered with vardenafil (20 mg film-coated tablets).
Po sočasni uporabi varfarina (25 mg), ki se presnavlja s pomočjo CYP2C9, ali digoksina (0,375 mg) z vardenafilom (20 mg filmsko obložene tablete) se ni pojavila nobena pomembnejša interakcija.
The total body clearance of vardenafil is 56 l/h with a resultant terminal half-life of approximately 4-5 hours.
Celoten očistek vardenafila iz telesa znaša 56 l/h.
Magnesium stearate, aspartame (E951), peppermint flavour, mannitol (E421), sorbitol (E420), crospovidone and silica colloidal hydrated.
- Druge sestavine zdravila so: magnezijev stearat, aspartam (E951), aroma poprove mete, manitol (E421), sorbitol (E420), krospovidon in hidratirani koloidni silicijev dioksid.
In patients with severe renal impairment (creatinine clearance <30 ml/min) a starting dose of Levitra 5 mg film-coated tablets should be considered.
Začetni odmerek za bolnike s hudo ledvično okvaro (kreatininski očistek < 30 ml/min) je zdravilo Levitra 5 mg filmsko obložene tablete.
Hypotension Hypertension
Žilne bolezni rdečica hipertenzija hipotenzija
The maximum dose recommended in patients with moderate hepatic impairment (Child-Pugh B) is 10 mg (see sections 4.3 and 5.2).
Največji priporočen odmerek za bolnike z zmerno jetrno okvaro (Child-Pugh B) je 10 mg (glejte poglavji 4.3 in
In the predefined subgroups 57% (elderly patients), 56% (patients with history of diabetes mellitus), 59% (patients with history of dyslipidemia) and 60% (patients with history of hypertension) of all reported attempts with vardenafil 10 mg orodispersible tablets were successful in terms of maintenance of erection.
V predhodno opredeljenih podskupinah bolnikov, ki so dobivali orodisperzibilne tablete po 10 mg vardenafila, so pri 57 % (starejši bolniki), 56 % (bolniki za anamnezo sladkorne bolezni), 59 % (bolniki z anamnezo displipidemije) in 60 % (bolniki z anamnezo hipertenzije) poročali, da je bilo občevanje uspešno; bolniki so ohranili erekcijo.
There is no relevant indication for use of Levitra in children.
Ustreznih indikacij za uporabo zdravila Levitra pri otrocih in mladostnikih ni.